HDL Therapeutics — Time for a Curtain Call or Time to Reconceptualize?
New England Journal of Medicine · 2024
DOI: 10.1056/nejme2403036 ↗Kurz gefasst
Editorial in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Christie M Ballantyne und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Medicine, Baylor College of Medicine (C.M.B., V.N.), the Texas Heart Institute (C.M.B.), and the Department of Medicine, Micha…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Cholesterol, HDL, Hypolipidemic Agents, Lipid Metabolism. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
The identification of an inverse association between high-density lipoprotein (HDL) cholesterol levels and incident cardiovascular disease events, 1 combined with research on the role of HDL in reverse cholesterol transport, led to the exploration of therapies directed toward increasing HDL cholesterol. However, although therapies such as cholesteryl-ester transfer protein inhibitors increased HDL cholesterol levels, these therapies did not reduce the incidence of cardiovascular disease events. 1,2 Consequently, the focus of HDL therapeutics shifted to attempting to improve the functionality, or quality, of HDL, and efforts to measure and enhance cholesterol efflux capacity and thereby promote reverse cholesterol transport were initiated. 1,2 Although the . . .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Medicine, Baylor College of Medicine (C.M.B., V.N.), the Texas Heart Institute (C.M.B.), and the Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center (V.N.) - all in Houston.
Zitieren
APA
Ballantyne, C. M., & Nambi, V. (2024). HDL Therapeutics — Time for a Curtain Call or Time to Reconceptualize?. New England Journal of Medicine. https://doi.org/10.1056/nejme2403036
Vancouver
Ballantyne CM, Nambi V. HDL Therapeutics — Time for a Curtain Call or Time to Reconceptualize?. New England Journal of Medicine. 2024. doi:10.1056/nejme2403036
BibTeX
@article{Ballantyne2024,
author = {Ballantyne, Christie M and Nambi, Vijay},
title = {HDL Therapeutics — Time for a Curtain Call or Time to Reconceptualize?},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejme2403036}
}
EUVIMED